The United States will resume use of Johnson & Johnson's COVID-19 vaccine, top health regulators said on Friday, ending a 10-day pause to investigate the vaccine's link to extremely rare but potentially deadly blood clots.
U.S. to resume use of Johnson & Johnson COVID-19 vaccine
Loading...